These 2 FTSE 250 flyers are up 60% in just 12 months

Investors in these two FTSE 250 (INDEXFTSE:MCX) companies have plenty to celebrate, says Harvey Jones.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

These FTSE 250 rockets have put on an impressive display to soar 60% in the past 12 months, but can the fireworks continue?

Life’s a gas

Kazakhstan-focused multi-field oil and gas company Nostrum Oil & Gas (LSE: NOG) has hit the highs lately. Like other companies in the sector, it was given a lift by the OPEC and non-OPEC production cuts at the end of last year, but unlike many of them, it has held onto its gains even as oil has slipped back to around $50 a barrel.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Nostrum’s Q1 results, published last month showed revenues leaping 51% from $73.9m to $111.9m year-on-year, the strongest in more than 12 months, with net operating cash flows soaring from $27m to $69.8m. That partly explains its successful share price showing, as does rising production, a slight dip in net debt to $841.3m and a 21.5% improvement in its closing cash position to $122.8m. 

The $50 question

It isn’t hard to see Nostrum’s appeal to investors: operating costs of less than $4 per barrel give it handsome margins. Management is nonetheless determined to keep the lid on operating costs to brace against sub-$50 a barrel oil, putting it in a much stronger position than many oil stocks.

The outlook seems promising, with its KazTransOil (KTO) pipeline connection set to complete and analysts predicting revenues of £372m this year, rising to £578m in 2018. If correct, earnings per share (EPS) could rise a whopping 257% next year. Forecasters expect its valuation to fall from 34.8 times earnings to just 9.8 times. I am wary of oil stocks at the moment, amid signs that OPEC members are starting to cheat on production cuts, but Nostrum looks like an honourable exception.

Indivior-ism

Speciality pharmaceuticals business Indivior (LSE: INDV) is also up 60% over the past year, although share price growth has slowed in recent months. The £2.33bn company specialises in addiction treatment, where it has 20 years of experience, and investors have been attracted by its strong market position and product pipeline.

However, the company has run into controversy, with 35 US states filing a joint civil complaint over its conduct with its heroin replacement Suboxone product, after it allegedly switched treatment from tablet to film formulation to block the introduction of generic alternatives. It incurred a $220m litigation charge in Q3 that knocked pre-tax profit from $258m to $98m, dampening share price growth.

Film star

Indivior nonetheless expects full-year 2017 net revenues of between $1.05bn and $1.08bn, buoyed by a rapidly rising treatment market and strong product pipeline. Q1 results show a solid business with resilient sales of Suboxone film, and net revenue rising 3% to $265m.

Management is in talks with the Department of Justice about a possible resolution to its litigation investigation and is also awaiting the outcome of patent challenge trials with Dr Reddy’s, Actavis and Par. It otherwise looks healthy with operating profit up 27% to $128m and net cash of $182m. I expect Indivior’s recent share price sogginess to continue as litigation threats drag on and forecasters predict EPS will drop 8% this year, then rebound 5% in 2018, but the long-term looks more promising.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Female florist with Down's syndrome working in small business
Investing Articles

2 promising penny stocks to buy on the dip

As stock markets continue to correct, I am hunting for oversold penny stocks that I think could help turbocharge my…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

I wouldn’t buy Bitcoin today. FTSE value stocks look much better value to me

Now looks like a promising time to buy UK value stocks, while Bitcoin still looks far too risky for me.

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

The Rolls-Royce share price is below 85p. Here’s what I’m doing!

The Rolls-Royce share price has suffered this year. Trading for below 85p, this Fool decides whether this is an opportunity…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

4 dividend stocks to buy as inflation soars!

I'm hunting for the best dividend stock to invest in as global inflation soars. Here are several high-dividend-yield shares that…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

UK shares to buy now: 3 big fallers I’d snap up

Our writer thinks this trio of strong business performers could be attractive UK shares to buy now for his portfolio.

Read more »

Lady researching stocks
Investing Articles

Could a falling stock market help me get rich?

When the stock market falls, what does it mean for our writer's portfolio? Here's why it could be an opportunity.

Read more »

Hand holding pound notes
Investing Articles

Should I buy these two 12%-yielding dividend shares for my Stocks and Shares ISA?

Do these double-digit dividend yielders offer our author the right balance of risk and reward for his Stocks and Shares…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 reasons to buy Lloyds shares at 43p

Our writer outlines three factors that make him bullish on Lloyds shares, as well as one noteworthy risk facing the…

Read more »